These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 3141002)

  • 41. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E; Hefti F; Wurtman RJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of haloperidol administration on in vivo extracellular dopamine in striatum and prefrontal cortex after partial dopamine lesions.
    Bean AJ; Roth RH
    Brain Res; 1991 May; 549(1):155-8. PubMed ID: 1909923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
    Cass WA; Peters LE
    Neurochem Int; 2010 Nov; 57(5):540-6. PubMed ID: 20615442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats.
    Geula C; Slevin JT
    Synapse; 1989; 4(3):248-53. PubMed ID: 2532792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
    Melamed E; Durst R; Frucht Y; Globus M
    Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S; Herregodts P; Deleu D; Devrieze A; De Klippel N; Ebinger G; Michotte Y
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):277-85. PubMed ID: 1407014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
    Abercrombie ED; Bonatz AE; Zigmond MJ
    Brain Res; 1990 Aug; 525(1):36-44. PubMed ID: 2123121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra.
    Dentresangle C; Le Cavorsin M; Savasta M; Leviel V
    Brain Res; 2001 Mar; 893(1-2):178-85. PubMed ID: 11223005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholinergic stimulation of substantia nigra: abolition of carbachol-induced eating by unilateral 6-hydroxydopamine lesion of nigrostriatal dopamine neurones.
    Parker GC; Rugg EL; Winn P
    Exp Brain Res; 1991; 87(3):597-603. PubMed ID: 1723691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNF.
    Cass WA; Peters LE
    Neurochem Res; 2010 May; 35(5):727-34. PubMed ID: 20119638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
    Sivam SP
    Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Striatal dopamine levels after unilateral lesions of the substantia nigra: evidence for a contralateral decrease.
    Hahn Z; Karádi Z; Lénárd L
    Acta Physiol Acad Sci Hung; 1981; 57(3):249-53. PubMed ID: 6795897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis.
    Zetterström T; Herrera-Marschitz M; Ungerstedt U
    Brain Res; 1986 Jun; 376(1):1-7. PubMed ID: 3087581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective inhibition of monoamine oxidase A or B reduces striatal oxidative stress in rats with partial depletion of the nigro-striatal dopaminergic pathway.
    Aluf Y; Vaya J; Khatib S; Loboda Y; Finberg JP
    Neuropharmacology; 2013 Feb; 65():48-57. PubMed ID: 22982254
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size.
    Castañeda E; Whishaw IQ; Robinson TE
    J Neurosci; 1990 Jun; 10(6):1847-54. PubMed ID: 1693953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.